Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude

NCT02523547 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Cavir
DRUG: Baraclude

Sponsor

Hanmi Pharmaceutical Company Limited